BP (BP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of this oil ...
BP PLC ADR reached a 52-week high, with its stock price climbing to 39.51 USD. This milestone reflects a significant upward trend for the energy giant over the past year, during which the stock has ...
BP is upgraded to Buy, driven by a strategic pivot to value, high-margin hydrocarbon production, and disciplined capital allocation. BP's Q4 results showed strong operational resilience, robust cash ...
BP is advancing plans to sell its Gelsenkirchen refinery in Germany. Sale talks are reportedly ongoing with Klesch Group. The ...
Azule Energy, BP's joint venture in Angola, has reported a fourth major hydrocarbon discovery and started oil production from the Ndungu field offshore. Lightsource bp has agreed to sell a 1GW solar ...
Industrials are the "it" sector of the stock market for hedge funds. Goldman Sachs analyzed regulatory filings from more than ...
BP reported its fourth-quarter and full-year 2025 results on 10 February 2026, showing underlying replacement cost profit of $7.5 billion for the year and $1.5 billion for the quarter, supported by ...
BP has filed a Form 6-K for the period ended 31 December 2025, providing management’s discussion and analysis, consolidated financial statements, details of legal proceedings, and capitalization and ...
Why Aker BP (OB:AKRBP) is Back on Investor Radars Aker BP (OB:AKRBP) has drawn fresh attention after recent share price moves, with the stock last closing at NOK 275.10 and showing mixed returns over ...
Good afternoon and good morning, everyone, and thank you for your interest in BP's Full Year 2025 results. I'm delighted to welcome our guests in the room and those on the webcast. I'm joined today by ...
BP share price continued its strong bull run last week as it reached its highest level since April 2024, continuing a recovery that started in April when it bottomed at 315p. It is slowly nearing the ...
Tuesday will see the release of results from BP, AstraZeneca, Barclays and Dunelm. As far as BP is concerned, UBS noted that the oil giant’s Q4 statement on 14 January pointed towards an operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results